FOXP3 and neoplasm: Application of TREM-1 signaling inhibitor GF9 statistically decreased CCR6+Foxp3+ Tregs infiltration, increasing the therapeutic efficacy of ICBs, as a result postponed tumor progression (Wu et al., 2019).